• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌长期幸存者

Long-term survivors after breast cancer.

作者信息

Dixon J M, Page D L, Anderson T J, Lee D, Elton R A, Stewart H J, Forrest A P

出版信息

Br J Surg. 1985 Jun;72(6):445-8. doi: 10.1002/bjs.1800720614.

DOI:10.1002/bjs.1800720614
PMID:4016513
Abstract

A retrospective analysis of two groups of patients, one surviving 16-20 years and the other dying within 10 years after diagnosis and treatment of primary breast cancer has been undertaken to determine whether there were particular clinical or histological features associated with long-term survival. The striking histological difference between the tumours of the two groups of patients was the prevalence of tumours of 'special' invasive types (cribriform, tubular, lobular and medullary) in the long-term survivors. Micro-invasive and non-invasive carcinomas were also more common in the survivors. The tumours of the surviving group which were not of a 'special' type more commonly had a better histological grade than those tumours of patients dying early from breast cancer. In the overall group elastosis was present in significantly more tumours of the survivors whereas tumour necrosis, vascular and lymphatic invasion were all significantly more common in the short-term survival group. Although there was a significantly increased incidence of earlier stage tumours in the long-term survivors, the histological distinctions between the two groups were independent of the differences in clinical features.

摘要

对两组原发性乳腺癌患者进行了回顾性分析,一组存活16至20年,另一组在诊断和治疗后10年内死亡,以确定是否存在与长期存活相关的特定临床或组织学特征。两组患者肿瘤之间显著的组织学差异在于长期存活者中“特殊”浸润性类型(筛状、管状、小叶状和髓样)肿瘤的患病率。微浸润癌和非浸润癌在存活者中也更常见。存活组中不属于“特殊”类型的肿瘤,其组织学分级通常比早期死于乳腺癌患者的肿瘤更好。在总体组中,弹性组织变性在存活者的肿瘤中明显更多见,而肿瘤坏死、血管和淋巴管浸润在短期存活组中都明显更常见。尽管长期存活者中早期肿瘤的发病率显著增加,但两组之间的组织学差异与临床特征的差异无关。

相似文献

1
Long-term survivors after breast cancer.乳腺癌长期幸存者
Br J Surg. 1985 Jun;72(6):445-8. doi: 10.1002/bjs.1800720614.
2
The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.乳腺癌根治术后存活25年患者的病理检查结果。
Cancer. 1982 Nov 15;50(10):2131-8. doi: 10.1002/1097-0142(19821115)50:10<2131::aid-cncr2820501027>3.0.co;2-a.
3
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.内乳淋巴结照射对淋巴结阴性乳腺癌患者长期预后及对侧乳腺癌发生率的影响。
Radiother Oncol. 2013 Aug;108(2):259-65. doi: 10.1016/j.radonc.2013.06.028. Epub 2013 Jul 25.
4
Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.通过肿瘤反应动态建模识别原发性乳腺癌长期存活者
Br J Cancer. 2000 Jul;83(1):98-103. doi: 10.1054/bjoc.2000.1216.
5
Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.浸润性多形性小叶组织学是乳腺癌患者生存的不良预后因素。
Am Surg. 2017 Apr 1;83(4):359-364.
6
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up.乳腺癌的病理预后因素。II. 组织学类型。一项长期随访的大型研究中与生存的关系。
Histopathology. 1992 Jun;20(6):479-89. doi: 10.1111/j.1365-2559.1992.tb01032.x.
7
[Lobular invasive breast cancer prognostic factors: About 940 patients].小叶浸润性乳腺癌的预后因素:约940例患者
Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16.
8
An overview of prognostic factors for long-term survivors of breast cancer.乳腺癌长期幸存者的预后因素概述。
Breast Cancer Res Treat. 2008 Feb;107(3):309-30. doi: 10.1007/s10549-007-9556-1. Epub 2007 Mar 22.
9
Classification and grading of invasive breast carcinoma.浸润性乳腺癌的分类与分级
Verh Dtsch Ges Pathol. 2005;89:35-44.
10
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.具有基底和肌上皮分化的乳腺癌的形态学和免疫表型分析
J Pathol. 2006 Mar;208(4):495-506. doi: 10.1002/path.1916.

引用本文的文献

1
Wnt7a Deficiency Could Predict Worse Disease-Free and Overall Survival in Estrogen Receptor-Positive Breast Cancer.Wnt7a基因缺失可预测雌激素受体阳性乳腺癌患者更差的无病生存期和总生存期。
J Breast Cancer. 2017 Dec;20(4):361-367. doi: 10.4048/jbc.2017.20.4.361. Epub 2017 Dec 19.
2
Core biopsy as a tool in planning the management of invasive breast cancer.核心活检作为规划浸润性乳腺癌治疗方案的一种工具。
World J Surg Oncol. 2005 Jan 4;3(1):1. doi: 10.1186/1477-7819-3-1.
3
Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.
细胞周期调节蛋白p34cdc2、p21waf1和p53在淋巴结阴性浸润性导管癌中的表达
Mol Pathol. 2003 Dec;56(6):328-35. doi: 10.1136/mp.56.6.328.
4
Preoperative assessment of prognostic factors in breast cancer.乳腺癌预后因素的术前评估。
J Clin Pathol. 2001 Jan;54(1):20-4. doi: 10.1136/jcp.54.1.20.
5
Pathology characteristics that optimize outcome prediction of a breast screening trial.优化乳腺癌筛查试验结果预测的病理学特征。
Br J Cancer. 2000 Aug;83(4):487-92. doi: 10.1054/bjoc.2000.1286.
6
Prospective evaluation of prognostic factors in operable breast cancer.可手术乳腺癌预后因素的前瞻性评估。
Br J Cancer. 1996 Nov;74(9):1469-78. doi: 10.1038/bjc.1996.567.
7
A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer.一项关于免疫组织化学测定的激素受体和核特征作为原发性乳腺癌早期复发预测指标的前瞻性分析。
Breast Cancer Res Treat. 1995;36(1):11-21. doi: 10.1007/BF00690180.
8
Oestrogen receptor activity in breast cancer detected at a prevalence screening examination.
Breast Cancer Res Treat. 1987 Dec;10(3):267-72. doi: 10.1007/BF01805763.
9
Epidermal growth factor receptor status of histological sub-types of breast cancer.乳腺癌组织学亚型的表皮生长因子受体状态
Br J Cancer. 1988 Oct;58(4):458-60. doi: 10.1038/bjc.1988.240.
10
Oestrogen receptor activity in intraduct and invasive breast carcinomas.导管内癌和浸润性乳腺癌中的雌激素受体活性
Breast Cancer Res Treat. 1987;9(2):129-33. doi: 10.1007/BF01807365.